Long lasting efficacy of Bezalip retard on the regulation of lipid levels after discontinuation of administration in patients with hyperlipoproteinemia.

• Authors: A Császár, I Karádi, G Köszegi, G Pados, M Németh-Csóka, M Pichler, L Romics
• Journal: Klinische Wochenschrift (Klin Wochenschr) Vol. 68 Suppl 22 Pg. 96-8 ( 1990) ISSN: 0023-2173 [Print] Germany
• PMID: 2087089 (Publication Type: Journal Article)

Chemical References

• Blood Glucose
• Cholesterol, HDL
• Cholesterol, LDL
• Delayed-Action Preparations
• Lipids
• Triglycerides
• Cholesterol
• Alkaline Phosphatase
• Bezafibrate

Topics

• Adult
• Aged
• Alkaline Phosphatase (blood)
• Bezafibrate (administration & dosage)
• Blood Glucose (metabolism)
• Cholesterol (blood)
• Cholesterol, HDL (blood)
• Cholesterol, LDL (blood)
• Delayed-Action Preparations
• Female
• Humans
• Hyperlipoproteinemia Type II (drug therapy, enzymology)
• Lipids (blood)
• Male
• Middle Aged
• Triglycerides (blood)